首页|布鲁氏菌病诊断标志物与治疗靶点研究进展

布鲁氏菌病诊断标志物与治疗靶点研究进展

扫码查看
布鲁氏菌病(布病)是由布鲁氏杆菌感染引起的人畜共患传染病.从细胞、蛋白和基因3个层面综述了布病诊断标志物的研究进展,细胞水平的研究提示布鲁氏菌感染后的外周血巨噬细胞、T细胞的亚群特征,多形核中性粒细胞计数,以及巨噬细胞特殊能量代谢途径可辅助诊断布病;蛋白水平的研究提示重组布鲁氏菌外膜蛋白2b可辅助诊断布病;基因水平的研究提示某些微小RNA、长链非编码RNA可辅助诊断布病.从疫苗研发和新型蛋白质靶点2个层面综述了布病治疗靶点的研究进展,二磷酸脲苷-葡萄糖焦磷酸化酶是疫苗研发和药物制备的重要靶点,布鲁氏菌感染后的某些功能性效应蛋白可成为布病的潜在治疗靶点.
Research progress on diagnosis markers and treatment targets of Brucellosis
Brucellosis is a widespread zoonotic disease caused by Brucella infection,which poses a significant risk to both human and animal health.Despite efforts to control its spread,the incidence of brucellosis in China continues to rise.Unfortunately,due to the non-specific symptoms of brucellosis,misdiagnosis,and mistreatment often result in chronic and recurring illness,leading to a significant burden on the society.In this review,we summarize recent research progress on potential diagnosis markers of brucellosis from perspectives of proteins,genes,and cells,as well as potential treatment targets of brucellosis from perspectives of vaccine development and new type protein targets,providing a comprehensive summary of new knowledge and perspectives for the development of precise diagnostic and therapeutic strategies for brucellosis.

BrucellaBrucellosisdiagnosis makersinfectious diseasetreatment targets

王波、丁海涛

展开 >

内蒙古自治区人民医院临床检验医学中心,呼和浩特 010017

布鲁氏杆菌 布鲁氏菌病 诊断标志物 传染病 治疗靶点

内蒙古医学科学院公立医院科研联合基金科技项目内蒙古自治区卫生健康委员会医疗卫生科技计划项目

2023GLLH0060202201054

2024

科技导报
中国科学技术协会

科技导报

CSTPCD北大核心
影响因子:0.559
ISSN:1000-7857
年,卷(期):2024.42(11)
  • 6